Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics

• Lisa Bartmann,
• Lisa Bartmann,
• David Schumacher,
• Saskia von Stillfried,
• Marieke Sternkopf,
• Setareh Alampour-Rajabi,
• Marc A. M. J. van Zandvoort,
• Marc A. M. J. van Zandvoort,
• Fabian Kiessling,
• Zhuojun Wu,
• Zhuojun Wu

Affiliations

Lisa Bartmann

Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, Germany

Lisa Bartmann

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany

David Schumacher

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany

Saskia von Stillfried

Institute of Pathology, University Clinic, RWTH Aachen University, Aachen, Germany

Marieke Sternkopf

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany

Setareh Alampour-Rajabi

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany

Marc A. M. J. van Zandvoort

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany

Marc A. M. J. van Zandvoort

Department of Genetics and Molecular Cell Biology, School for Cardiovascular Diseases (CARIM), School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, Netherlands

Fabian Kiessling

Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, Germany

Zhuojun Wu

Institute for Experimental Molecular Imaging, University Clinic, RWTH Aachen University, Aachen, Germany

Zhuojun Wu

Institute for Molecular Cardiovascular Research, University Clinic, RWTH Aachen University, Aachen, Germany